Home/ Stocks/ PRPO

Precipio, Inc. Common Stock

PRPO XNAS

$29.81 -0.59 (-1.94%) ▼ 15-min delayed

Open

$30.45

High

$30.45

Low

$29.39

Volume

20.9K

Market Cap

$53.21M

About Precipio, Inc. Common Stock

Precipio Inc is a healthcare biotechnology company focused on cancer diagnostics. It focuses on improving cancer diagnostics, particularly hematologic malignancies. Its objective is to enhance diagnostic accuracy and accessibility while building a sustainable business model that supports ongoing innovation. The company operates Clinical Laboratory Improvement Amendments laboratories in both New Haven, Connecticut, and Omaha, Nebraska, providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. The company operates in a single segment, which includes two divisions: the Pathology Services Division and the Products Division.

Sector: LABORATORY ANALYTICAL INSTRUMENTS Employees: 71 Website →

Key Financials

Period	Revenue	Net Income	EPS
TTM 2025	$24.05M	$-363,000	$-0.23
FY 2025	$24.05M	$-363,000	$-0.23
Q3 2025	$6.77M	$-79,000	$-0.05
Q1 2025	$4.93M	$-884,000	$-0.59

Related Market News

No specific coverage for PRPO yet. Check out our latest market news or earnings calendar.

Get PRPO Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Precipio, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.